Skip to main content

Table 1 Patient characteristics for the two groups

From: Microcirculatory effects of the transfusion of leukodepleted or non-leukodepleted red blood cells in patients with sepsis: a pilot study

 

Non-leukodepleted group

Leukodepleted group

 

n = 10

n = 10

Age, years

70 (65–72)

74 (64–79)

Sex, male; female

5; 5

7; 3

SAPS II on admission

37 (28–74)

41 (35–47)

ICU days before enrollment

9 (8–12)

9 (4–29)

Sepsis, number

2

5

Severe sepsis, number

3

2

Septic shock, number

5

3

Source of infection, number

  

Lung

4

3

Abdomen

1

3

Urinary tract

2

1

Miscellaneous

3

3

Adrenergic dosea

  

Norepinephrine

5; 0.047 (0.015–0.370)

3; 0.155 (0.050–0.260)

Dobutamine

1; 2.074 (2.074–2.074)

1; 2.31 (2.31–2.31)

  1. aNumber of patients; median dose in μg/kg*min (interquartile range). ICU, intensive care unit; SAPS II, Simplified Acute Physiology Score II.